[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Passive Transdermal Drug Delivery Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

August 2023 | 109 pages | ID: G4A791B3966AEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Passive Transdermal Drug Delivery market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Passive Transdermal Drug Delivery market are covered in Chapter 9:

Actavis, Inc.
Echo Therapeutics, Inc.
Corium International, Inc.
Noven Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
3M
Transdermal Corp.
Bayer AG
Novartis AG
Mylan N.V.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)

In Chapter 5 and Chapter 7.3, based on types, the Passive Transdermal Drug Delivery market from 2017 to 2027 is primarily split into:

Microfluidics
Smart Pill Technology (SPT)

In Chapter 6 and Chapter 7.4, based on applications, the Passive Transdermal Drug Delivery market from 2017 to 2027 covers:

Clinic
Hospital
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Passive Transdermal Drug Delivery market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Passive Transdermal Drug Delivery Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 PASSIVE TRANSDERMAL DRUG DELIVERY MARKET OVERVIEW

1.1 Product Overview and Scope of Passive Transdermal Drug Delivery Market
1.2 Passive Transdermal Drug Delivery Market Segment by Type
  1.2.1 Global Passive Transdermal Drug Delivery Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Passive Transdermal Drug Delivery Market Segment by Application
  1.3.1 Passive Transdermal Drug Delivery Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Passive Transdermal Drug Delivery Market, Region Wise (2017-2027)
  1.4.1 Global Passive Transdermal Drug Delivery Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.3 Europe Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.4 China Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.5 Japan Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.6 India Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.8 Latin America Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Passive Transdermal Drug Delivery Market Status and Prospect (2017-2027)
1.5 Global Market Size of Passive Transdermal Drug Delivery (2017-2027)
  1.5.1 Global Passive Transdermal Drug Delivery Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Passive Transdermal Drug Delivery Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Passive Transdermal Drug Delivery Market

2 INDUSTRY OUTLOOK

2.1 Passive Transdermal Drug Delivery Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Passive Transdermal Drug Delivery Market Drivers Analysis
2.4 Passive Transdermal Drug Delivery Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Passive Transdermal Drug Delivery Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Passive Transdermal Drug Delivery Industry Development

3 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET LANDSCAPE BY PLAYER

3.1 Global Passive Transdermal Drug Delivery Sales Volume and Share by Player (2017-2022)
3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Player (2017-2022)
3.3 Global Passive Transdermal Drug Delivery Average Price by Player (2017-2022)
3.4 Global Passive Transdermal Drug Delivery Gross Margin by Player (2017-2022)
3.5 Passive Transdermal Drug Delivery Market Competitive Situation and Trends
  3.5.1 Passive Transdermal Drug Delivery Market Concentration Rate
  3.5.2 Passive Transdermal Drug Delivery Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Passive Transdermal Drug Delivery Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Passive Transdermal Drug Delivery Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Passive Transdermal Drug Delivery Market Under COVID-19
4.5 Europe Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Passive Transdermal Drug Delivery Market Under COVID-19
4.6 China Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Passive Transdermal Drug Delivery Market Under COVID-19
4.7 Japan Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Passive Transdermal Drug Delivery Market Under COVID-19
4.8 India Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Passive Transdermal Drug Delivery Market Under COVID-19
4.9 Southeast Asia Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Passive Transdermal Drug Delivery Market Under COVID-19
4.10 Latin America Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Passive Transdermal Drug Delivery Market Under COVID-19
4.11 Middle East and Africa Passive Transdermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Passive Transdermal Drug Delivery Market Under COVID-19

5 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Passive Transdermal Drug Delivery Sales Volume and Market Share by Type (2017-2022)
5.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2017-2022)
5.3 Global Passive Transdermal Drug Delivery Price by Type (2017-2022)
5.4 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate of Microfluidics (2017-2022)
  5.4.2 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Growth Rate of Smart Pill Technology (SPT) (2017-2022)

6 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET ANALYSIS BY APPLICATION

6.1 Global Passive Transdermal Drug Delivery Consumption and Market Share by Application (2017-2022)
6.2 Global Passive Transdermal Drug Delivery Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Passive Transdermal Drug Delivery Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Clinic (2017-2022)
  6.3.2 Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Hospital (2017-2022)
  6.3.3 Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET FORECAST (2022-2027)

7.1 Global Passive Transdermal Drug Delivery Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Passive Transdermal Drug Delivery Price and Trend Forecast (2022-2027)
7.2 Global Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Passive Transdermal Drug Delivery Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Passive Transdermal Drug Delivery Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Passive Transdermal Drug Delivery Revenue and Growth Rate of Microfluidics (2022-2027)
  7.3.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate of Smart Pill Technology (SPT) (2022-2027)
7.4 Global Passive Transdermal Drug Delivery Consumption Forecast by Application (2022-2027)
  7.4.1 Global Passive Transdermal Drug Delivery Consumption Value and Growth Rate of Clinic(2022-2027)
  7.4.2 Global Passive Transdermal Drug Delivery Consumption Value and Growth Rate of Hospital(2022-2027)
  7.4.3 Global Passive Transdermal Drug Delivery Consumption Value and Growth Rate of Others(2022-2027)
7.5 Passive Transdermal Drug Delivery Market Forecast Under COVID-19

8 PASSIVE TRANSDERMAL DRUG DELIVERY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Passive Transdermal Drug Delivery Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Passive Transdermal Drug Delivery Analysis
8.6 Major Downstream Buyers of Passive Transdermal Drug Delivery Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Passive Transdermal Drug Delivery Industry

9 PLAYERS PROFILES

9.1 Actavis, Inc.
  9.1.1 Actavis, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.1.3 Actavis, Inc. Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Echo Therapeutics, Inc.
  9.2.1 Echo Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.2.3 Echo Therapeutics, Inc. Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Corium International, Inc.
  9.3.1 Corium International, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.3.3 Corium International, Inc. Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Noven Pharmaceuticals, Inc.
  9.4.1 Noven Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.4.3 Noven Pharmaceuticals, Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Boehringer Ingelheim GmbH
  9.5.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.5.3 Boehringer Ingelheim GmbH Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 GlaxoSmithKline plc
  9.6.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.6.3 GlaxoSmithKline plc Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 3M
  9.7.1 3M Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.7.3 3M Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Transdermal Corp.
  9.8.1 Transdermal Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.8.3 Transdermal Corp. Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Bayer AG
  9.9.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.9.3 Bayer AG Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Novartis AG
  9.10.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.10.3 Novartis AG Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Mylan N.V.
  9.11.1 Mylan N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.11.3 Mylan N.V. Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  9.12.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
  9.12.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Passive Transdermal Drug Delivery Product Picture
Table Global Passive Transdermal Drug Delivery Market Sales Volume and CAGR (%) Comparison by Type
Table Passive Transdermal Drug Delivery Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Passive Transdermal Drug Delivery Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Passive Transdermal Drug Delivery Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Passive Transdermal Drug Delivery Industry Development
Table Global Passive Transdermal Drug Delivery Sales Volume by Player (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Volume Share by Player (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume Share by Player in 2021
Table Passive Transdermal Drug Delivery Revenue (Million USD) by Player (2017-2022)
Table Passive Transdermal Drug Delivery Revenue Market Share by Player (2017-2022)
Table Passive Transdermal Drug Delivery Price by Player (2017-2022)
Table Passive Transdermal Drug Delivery Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Passive Transdermal Drug Delivery Sales Volume, Region Wise (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share, Region Wise in 2021
Table Global Passive Transdermal Drug Delivery Revenue (Million USD), Region Wise (2017-2022)
Table Global Passive Transdermal Drug Delivery Revenue Market Share, Region Wise (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share, Region Wise (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share, Region Wise in 2021
Table Global Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Volume by Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Volume Market Share by Type (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume Market Share by Type in 2021
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) by Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Type in 2021
Table Passive Transdermal Drug Delivery Price by Type (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate of Microfluidics (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate of Microfluidics (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate of Smart Pill Technology (SPT) (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate of Smart Pill Technology (SPT) (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption by Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption Market Share by Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption Revenue Market Share by Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Clinic (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Hospital (2017-2022)
Table Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Others (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Passive Transdermal Drug Delivery Price and Trend Forecast (2022-2027)
Figure USA Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Passive Transdermal Drug Delivery Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Passive Transdermal Drug Delivery Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Passive Transdermal Drug Delivery Market Sales Volume Forecast, by Type
Table Global Passive Transdermal Drug Delivery Sales Volume Market Share Forecast, by Type
Table Global Passive Transdermal Drug Delivery Market Revenue (Million USD) Forecast, by Type
Table Global Passive Transdermal Drug Delivery Revenue Market Share Forecast, by Type
Table Global Passive Transdermal Drug Delivery Price Forecast, by Type
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate of Microfluidics (2022-2027)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate of Microfluidics (2022-2027)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate of Smart Pill Technology (SPT) (2022-2027)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate of Smart Pill Technology (SPT) (2022-2027)
Table Global Passive Transdermal Drug Delivery Market Consumption Forecast, by Application
Table Global Passive Transdermal Drug Delivery Consumption Market Share Forecast, by Application
Table Global Passive Transdermal Drug Delivery Market Revenue (Million USD) Forecast, by Application
Table Global Passive Transdermal Drug Delivery Revenue Market Share Forecast, by Application
Figure Global Passive Transdermal Drug Delivery Consumption Value (Million USD) and Growth Rate of Clinic (2022-2027)
Figure Global Passive Transdermal Drug Delivery Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Passive Transdermal Drug Delivery Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Passive Transdermal Drug Delivery Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Actavis, Inc. Profile
Table Actavis, Inc. Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Actavis, Inc. Revenue (Million USD) Market Share 2017-2022
Table Echo Therapeutics, Inc. Profile
Table Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Echo Therapeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Corium International, Inc. Profile
Table Corium International, Inc. Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Corium International, Inc. Revenue (Million USD) Market Share 2017-2022
Table Noven Pharmaceuticals, Inc. Profile
Table Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Noven Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Boehringer Ingelheim GmbH Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table 3M Profile
Table 3M Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure 3M Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure 3M Revenue (Million USD) Market Share 2017-2022
Table Transdermal Corp. Profile
Table Transdermal Corp. Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Transdermal Corp. Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Transdermal Corp. Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Mylan N.V. Profile
Table Mylan N.V. Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Mylan N.V. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Profile
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Volume and Growth Rate
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Revenue (Million USD) Market Share 2017-2022


More Publications